Repeated Treatment for Macular Edema in Vein Occlusion by Intravitreal Implant of Dexamethasone

Background: Macular edema (ME) treatment has benefited from the recent intravitreal pharmacotherapy development of an intravitreal implant of dexamethasone (Ozurdex®, Allergan, Irvine, Calif., USA). However, its efficiency has never been illustrated beyond 3 injections. Case Presentation: We report...

Full description

Bibliographic Details
Main Authors: Frederic Matonti, Louis Hoffart, Christophe Baeteman, Danièle Denis
Format: Article
Language:English
Published: Karger Publishers 2012-10-01
Series:Case Reports in Ophthalmology
Subjects:
Online Access:http://www.karger.com/Article/FullText/343643
_version_ 1811255301950668800
author Frederic Matonti
Louis Hoffart
Christophe Baeteman
Danièle Denis
author_facet Frederic Matonti
Louis Hoffart
Christophe Baeteman
Danièle Denis
author_sort Frederic Matonti
collection DOAJ
description Background: Macular edema (ME) treatment has benefited from the recent intravitreal pharmacotherapy development of an intravitreal implant of dexamethasone (Ozurdex®, Allergan, Irvine, Calif., USA). However, its efficiency has never been illustrated beyond 3 injections. Case Presentation: We report the case of a 75-year-old woman with inferior branch vein occlusion, who, after laser photocoagulation treatment and recurrence after intravitreal injection of triamcinolone, benefited from 4 injections of Ozurdex. Her macular thickness and visual acuity (VA) progression were assessed for 17 months. Conclusions: This case report highlights the quick efficiency of Ozurdex on VA and ME with good reproducibility and tolerance, and without tachyphylaxis phenomenon. This is the first illustrated description of 4 consecutive injections for ME induced secondary to retinal vein occlusion.
first_indexed 2024-04-12T17:21:52Z
format Article
id doaj.art-967ad6403dd0414d9411d0b101d9fb2f
institution Directory Open Access Journal
issn 1663-2699
language English
last_indexed 2024-04-12T17:21:52Z
publishDate 2012-10-01
publisher Karger Publishers
record_format Article
series Case Reports in Ophthalmology
spelling doaj.art-967ad6403dd0414d9411d0b101d9fb2f2022-12-22T03:23:27ZengKarger PublishersCase Reports in Ophthalmology1663-26992012-10-013333934210.1159/000343643343643Repeated Treatment for Macular Edema in Vein Occlusion by Intravitreal Implant of DexamethasoneFrederic MatontiLouis HoffartChristophe BaetemanDanièle DenisBackground: Macular edema (ME) treatment has benefited from the recent intravitreal pharmacotherapy development of an intravitreal implant of dexamethasone (Ozurdex®, Allergan, Irvine, Calif., USA). However, its efficiency has never been illustrated beyond 3 injections. Case Presentation: We report the case of a 75-year-old woman with inferior branch vein occlusion, who, after laser photocoagulation treatment and recurrence after intravitreal injection of triamcinolone, benefited from 4 injections of Ozurdex. Her macular thickness and visual acuity (VA) progression were assessed for 17 months. Conclusions: This case report highlights the quick efficiency of Ozurdex on VA and ME with good reproducibility and tolerance, and without tachyphylaxis phenomenon. This is the first illustrated description of 4 consecutive injections for ME induced secondary to retinal vein occlusion.http://www.karger.com/Article/FullText/343643Macular edemaVein occlusionIntravitreal implantDexamethasoneRanibizumabOptical coherence tomographyOzurdex®
spellingShingle Frederic Matonti
Louis Hoffart
Christophe Baeteman
Danièle Denis
Repeated Treatment for Macular Edema in Vein Occlusion by Intravitreal Implant of Dexamethasone
Case Reports in Ophthalmology
Macular edema
Vein occlusion
Intravitreal implant
Dexamethasone
Ranibizumab
Optical coherence tomography
Ozurdex®
title Repeated Treatment for Macular Edema in Vein Occlusion by Intravitreal Implant of Dexamethasone
title_full Repeated Treatment for Macular Edema in Vein Occlusion by Intravitreal Implant of Dexamethasone
title_fullStr Repeated Treatment for Macular Edema in Vein Occlusion by Intravitreal Implant of Dexamethasone
title_full_unstemmed Repeated Treatment for Macular Edema in Vein Occlusion by Intravitreal Implant of Dexamethasone
title_short Repeated Treatment for Macular Edema in Vein Occlusion by Intravitreal Implant of Dexamethasone
title_sort repeated treatment for macular edema in vein occlusion by intravitreal implant of dexamethasone
topic Macular edema
Vein occlusion
Intravitreal implant
Dexamethasone
Ranibizumab
Optical coherence tomography
Ozurdex®
url http://www.karger.com/Article/FullText/343643
work_keys_str_mv AT fredericmatonti repeatedtreatmentformacularedemainveinocclusionbyintravitrealimplantofdexamethasone
AT louishoffart repeatedtreatmentformacularedemainveinocclusionbyintravitrealimplantofdexamethasone
AT christophebaeteman repeatedtreatmentformacularedemainveinocclusionbyintravitrealimplantofdexamethasone
AT danieledenis repeatedtreatmentformacularedemainveinocclusionbyintravitrealimplantofdexamethasone